Department of Health. Getting ahead of the curve: a strategy for combating infectious diseases (including other aspects of health protection). A report by the chief medical officer. Technical report. Department of Health, London, 2002.
Boxall, EH, Flewett, TH. Prevalence of HBsAg in UK population. British Medical Journal
1987; 294: 57.
Hahné, S, et al.
Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy. Journal of Clinical Virology
2004; 29: 211–220.
Gay, NJ, et al.
The prevalence of hepatitis B infection in adults in England and Wales. Epidemiology and Infection
1999; 122: 133–138.
Boxall, E, et al.
The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiology and Infection
1994; 113: 523–528.
Caley, M, et al.
Differences in hepatitis B infection rate between ethnic groups in antenatal women in Birmingham, United Kingdom, May 2004 to December 2008. Eurosurveillance
2012; 17: 20228.
Siddiqui, MR, et al.
Economic evaluation of infant and adolescent hepatitis B vaccination in the UK. Vaccine
2011; 29: 466–475.
Salisbury, D, Ramsay, M, Noakes, K. Immunisation against Infectious Disease. London: The Stationery Office, 2006.
Buti, M, et al.
Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B. Journal of Hepatology
2009; 51: 640–646.
Custer, B, et al.
Global epidemiology of hepatitis B virus. Journal of Clinical Gastroenterology
2004; 38: 158–168.
Veldhuijzen, IK, et al.
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology
2010; 138: 522–530.
Wong, WW, et al.
Cost effectiveness of screening immigrants for hepatitis B. Liver International
2011; 31: 1179–1190.
Department of Health. Screening of pregnant women for hepatitis B and immunisation of babies at risk. Department of Health, London, 1998.
Lakha, F, Gorman, DR, Mateos, P. Name analysis to classify populations by ethnicity in public health: validation of Onomap in Scotland. Public Health
2011; 125: 688–696.
Tehami, N, et al.
Outcome of the management of hepatitis B infection in pregnancy. Gut
2011; 60 (Suppl. 1): A248–A249.
Wohland, P, et al. ETHPOP database, ESRC Follow on Fund ‘Ethnic group population trends’. University of Leeds, 2012 (http://www.ethpop.org).
Gungabissoon, U, Balogun, MA, Ramsay, ME. Hepatitis C virus: laboratory surveillance in England and Wales, 1992–2004. Epidemiology and Infection
2007; 4: 541–548.
Cowan, SA. Denmark scales up hepatitis B screening and vaccination for risk groups. Eurosurveillance
2005; 11: E051103.4.
Veldhuijzen, IK, Smits, LJ, van de Laar, MJ. The importance of imported infections in maintaining hepatitis B in The Netherlands. Epidemiology and Infection
2005; 1: 113–119.
Larcher, VF, et al.
Overcoming barriers to hepatitis B immunisation by a dedicated hepatitis B immunisation service. Archives of Disease in Childhood
2001; 2: 114–119.
The Scottish Government. The sexual health and blood borne virus framework, 2011–15. Technical report. The Scottish Government, 2011.